Gain in translation: heme oxygenase-1 induced by activated protein C promotes thrombus resolution

Por Deguchi, Hiroshi, Elias, Darlene J., Griffin, John H.
Publicado em 2014

Minor plasma lipids modulate clotting factor activities and may affect thrombosis risk

Por Deguchi, Hiroshi, Elias, Darlene J., Griffin, John H.
Publicado no Res Pract Thromb Haemost (2017)

Elevated CETP Lipid Transfer Activity is Associated with the Risk of Venous Thromboembolism

Por Deguchi, Hiroshi, Banerjee, Yajnavalka, Elias, Darlene J., Griffin, John H.
Publicado no J Atheroscler Thromb (2016)

Elevated serum amyloid A is associated with venous thromboembolism

Por Deguchi, Hiroshi, Elias, Darlene J., Navarro, Silvia, España, Francisco, Griffin, John H.
Publicado em 2012

Elevated plasma fibronectin levels associated with venous thromboembolism

Por Pecheniuk, Natalie M, Elias, Darlene J, Deguchi, Hiroshi, Averell, Patricia M, Griffin, John H
Publicado em 2008

Warfarin Untargeted Metabolomics Study Identifies Novel Procoagulant Ethanolamide Plasma Lipids

Por Deguchi, Hiroshi, Elias, Darlene J., Trauger, Sunia, Zhang, Hui-Min, Kalisiak, Ewa, Siuzdak, Gary, Griffin, John H.
Publicado em 2014

Association of Apo(a)Isoform Size with Dyslipoproteinemia in Male Venous Thrombosis Patients

Por Marcovina, Santica M., Cheung, Marian C, Kennedy, Hal, Deguchi, Hiroshi, Elias, Darlene, Averell, Patricia M, Griffin, John H, Albers, John J
Publicado em 2010

Inhibition of thrombin generation in human plasma by phospholipid transfer protein

Por Deguchi, Hiroshi, Wolfbauer, Gertrud, Cheung, Marian C., Banerjee, Yajnavalka, Elias, Darlene J., Fernández, José A., Albers, John J., Griffin, John H.
Publicado no Thromb J (2015)

Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients

Por Gale, Andrew J., Elias, Darlene J., Averell, Patricia M., Teirstein, Paul S., Buck, Mitchell, Brown, Steven D., Polonskaya, Zinaida, Udit, Andrew K., Finn, M.G.
Publicado em 2011

Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data

Por Deguchi, Hiroshi, Banerjee, Yajnavalka, Trauger, Sunia, Siuzdak, Gary, Kalisiak, Ewa, Fernández, José A., Hoang, Linh, Tran, Minerva, Yegneswaran, Subramanian, Elias, Darlene J., Griffin, John H.
Publicado no Blood (2015)

Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases

Por Deguchi, Hiroshi, Navarro, Silvia, Payne, Amanda B., Elias, Darlene J., Dowling, Nicole F., Austin, Harland D., España, Francisco, Medina, Pilar, Hooper, W. Craig, Griffin, John H.
Publicado no Res Pract Thromb Haemost (2017)

Arteriovenous Blood Metabolomics: A Readout of Intra-Tissue Metabostasis

Por Ivanisevic, Julijana, Elias, Darlene, Deguchi, Hiroshi, Averell, Patricia M., Kurczy, Michael, Johnson, Caroline H., Tautenhahn, Ralf, Zhu, Zhengjiang, Watrous, Jeramie, Jain, Mohit, Griffin, John, Patti, Gary J., Siuzdak, Gary
Publicado no Sci Rep (2015)

Prevalence and Risk Factors for Hypertension in Hemophilia

Por von Drygalski, Annette, Kolaitis, Nicholas A, Bettencourt, Ricki, Bergstrom, Jaclyn, Kruse-Jarres, R, Quon, Doris VK, Wassel, Christina, Li, Ming C, Waalen, Jill, Elias, Darlene J, Mosnier, Laurent O, Allison, Matthew
Publicado em 2013